Josh Lauring

4.1k citations

42 papers · 2.0k indexed · h-index 22

Impact in

Cancer Research top 5%
- Cancer Genomics and Diagnostics
Molecular Biology top 5%
- Epigenetics and DNA Methylation
- PI3K/AKT/mTOR signaling in cancer
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- RNA modifications and cancer

Papers in ⓘ

Cancer Research 11
- Cancer Genomics and Diagnostics 8
Pulmonary and Respiratory Medicine 14
- Advanced Breast Cancer Therapies 5

Co-authors: Ben Ho Park (17 shared papers)Mark S. Schlissel (3 shared papers)John P. Gustin (10 shared papers)Joseph P. Garay (9 shared papers)Kyung Hee Yi (4 shared papers)Abde M. Abukhdeir (8 shared papers)Hiroyuki Konishi (7 shared papers)Antonio C. Wolff (3 shared papers)
Journals: Journal of Clinical Oncology (5 papers)Oncotarget (5 papers)Annals of Oncology (3 papers)Journal of the National Comprehensive Cancer Network (3 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: United States Spain Netherlands

In The Last Decade

Josh Lauring

41 papers receiving 2.0k citations

Peers

Countries citing papers authored by Josh Lauring

Since Specialization

Citations

This map shows the geographic impact of Josh Lauring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh Lauring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh Lauring more than expected).

Fields of papers citing papers by Josh Lauring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josh Lauring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh Lauring. The network helps show where Josh Lauring may publish in the future.

Co-authors

The 25 scholars most cited alongside Josh Lauring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Josh Lauring Line = papers co-authored together Josh Lauring links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming Molecular Cell ·Alex Kuo, Peggie Cheung, Kaifu Chen, Barry M. Zee, Mitomu Kioi, Josh Lauring, Yuanxin Xi, Ben Ho Park, Xiaobing Shi, Benjamin A. García, Wei Li, Or Gozani	2011	322
2	Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton Cell ·Hai Hu, Ashish Juvekar, Costas A. Lyssiotis, Evan C. Lien, John G. Albeck, Doogie Oh, Gopal Varma, Yin P. Hung, Soumya Ullas, Josh Lauring, Pankaj Seth, Mark R. Lundquist, Dean R. Tolan, Aaron K. Grant, Daniel Needleman, John M. Asara, Lewis C. Cantley, Gerburg M. Wulf	2016	289
3	A Conserved Transcriptional Enhancer Regulates RAG Gene Expression in Developing B Cells Immunity ·Lih-Yun Hsu, Josh Lauring, Hong-Erh Liang, Stephen Greenbaum, Dragana Cado, Yuan Zhuang, Mark S. Schlissel	2003	122
4	Knockin of mutant PIK3CA activates multiple oncogenic pathways Proceedings of the National Academy of Sciences ·John P. Gustin, Bedri Karakas, Michele B. Weiss, Abde M. Abukhdeir, Josh Lauring, Joseph P. Garay, David Cosgrove, Akina Tamaki, Hiroyuki Konishi, Yuko Konishi, Morassa Mohseni, Grace Wang, Dina Rosen, Samuel R. Denmeade, Michaela J. Higgins, Michele Vítolo, Kurtis E. Bachman, Ben Ho Park	2009	120
5	The multiple myeloma–associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity Blood ·Josh Lauring, Abde M. Abukhdeir, Hiroyuki Konishi, Joseph P. Garay, John P. Gustin, Qiuju Wang, R.J. Arceci, William Matsui, Ben Ho Park	2007	117
6	The Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in Breast Cancer Journal of the National Comprehensive Cancer Network ·Josh Lauring, Ben Ho Park, Antonio C. Wolff	2013	92
7	Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA Clinical Biochemistry ·Patricia Valda Toro, Bracha Erlanger, Julia A. Beaver, Rory L. Cochran, Dustin A. VanDenBerg, Elizabeth Yakim, Karen Cravero, David Chu, Daniel J. Zabransky, Hong Yuen Wong, Sarah Croessmann, Heather A. Parsons, Paula J. Hurley, Josh Lauring, Ben Ho Park	2015	83
8	PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System Clinical Cancer Research ·Julia A. Beaver, John P. Gustin, Kyung Hee Yi, Anandita Rajpurohit, Matthew C. Thomas, Samuel F. Gilbert, David Rosen, Ben Ho Park, Josh Lauring	2013	76
9	Knock-in of Mutant K- ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K- ras –Mediated Transformation Cancer Research ·Hiroyuki Konishi, Bedri Karakas, Abde M. Abukhdeir, Josh Lauring, John P. Gustin, Joseph P. Garay, Yuko Konishi, Eike Gallmeier, Kurtis E. Bachman, Ben Ho Park	2007	74
10	Tamoxifen-stimulated growth of breast cancer due to p21 loss Proceedings of the National Academy of Sciences ·Abde M. Abukhdeir, Michele Vítolo, Pedram Argani, Angelo M. De Marzo, Bedri Karakas, Hiroyuki Konishi, John P. Gustin, Josh Lauring, Joseph P. Garay, Courtney Pendleton, Yuko Konishi, Brian Blair, Keith Brenner, Elizabeth Garrett‐Mayer, Hetty E. Carraway, Kurtis E. Bachman, Ben Ho Park	2007	70
11	Distinct Factors Regulate the Murine RAG-2 Promoter in B- and T-Cell Lines Molecular and Cellular Biology ·Josh Lauring, Mark S. Schlissel	1999	56
12	Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board JCO Precision Oncology ·W. Brian Dalton, Patrick M. Forde, Hyunseok Kang, Roisín M. Connolly, Vered Stearns, Christopher D. Gocke, James R. Eshleman, Jennifer E. Axilbund, Dana Petry, Cindy Geoghegan, Antonio C. Wolff, David M. Loeb, Christine A. Pratilas, Christian F. Meyer, Eric S. Christenson, Shannon A. Slater, Jennifer Ensminger, Heather A. Parsons, Ben Ho Park, Josh Lauring	2017	53
13	MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers Proceedings of the National Academy of Sciences ·Morassa Mohseni, Justin Cidado, Sarah Croessmann, Karen Cravero, Ashley Cimino‐Mathews, Hong Yuen Wong, Rob Scharpf, Daniel J. Zabransky, Abde M. Abukhdeir, Joseph P. Garay, Grace M. Wang, Julia A. Beaver, Rory L. Cochran, Brian Blair, Dina Rosen, Bracha Erlanger, Pedram Argani, Paula J. Hurley, Josh Lauring, Ben Ho Park	2014	52
14	Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity Oncotarget ·Kyung Hee Yi, Josh Lauring	2015	47
15	c-Myb Binds to a Sequence in the Proximal Region of the RAG-2 Promoter and Is Essential for Promoter Activity in T-Lineage Cells Molecular and Cellular Biology ·Qian‐Fei Wang, Josh Lauring, Mark S. Schlissel	2000	45
16	Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation The Oncologist ·Judy Wang, Patricia Martín-Romano, Philippe A. Cassier, Melissa L. Johnson, Eric B. Haura, Laurie Lenox, Yue Guo, Nibedita Bandyopadhyay, Michael J. Russell, Elizabeth Shearin, Josh Lauring, Laëtitia Dahan	2022	45
17	Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations Oncogene ·Josh Lauring, David Cosgrove, Stefani C. Fontana, John P. Gustin, Hiroyuki Konishi, Abde M. Abukhdeir, Joseph P. Garay, Morassa Mohseni, Guoli Wang, Michaela J. Higgins, David U. Gorkin, Marcelo Reis, Bert Vogelstein, Kornélia Polyák, Marianne Cowherd, Phillip Buckhaults, B H Park	2010	44
18	Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine Oncotarget ·Kyung Hee Yi, Jossette Axtmayer, John P. Gustin, Anandita Rajpurohit, Josh Lauring	2012	32
19	Results from molecular analysis for therapy choice (MATCH) arm I: Taselisib for PIK3CA-mutated tumors. Journal of Clinical Oncology ·Ian E. Krop, Opeyemi A. Jegede, Juneko E. Grilley‐Olson, Josh Lauring, Stanley R. Hamilton, James A. Zwiebel, Shuli Li, Larry Rubinstein, Austin Doyle, David R. Patton, Edith P. Mitchell, Carlos L. Arteaga, Barbara A. Conley, David Sims, Lyndsay N. Harris, Alice P. Chen, Keith T. Flaherty	2018	30
20	TMSB4Yis a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer Oncotarget ·Hong Yuen Wong, Grace M. Wang, Sarah Croessmann, Daniel J. Zabransky, David Chu, Joseph P. Garay, Justin Cidado, Rory L. Cochran, Julia A. Beaver, Anita Aggarwal, Min-Ling Liu, Pedram Argani, Alan K. Meeker, Paula J. Hurley, Josh Lauring, Ben Ho Park	2015	29

About Josh Lauring

Josh Lauring is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Genetics, having authored 42 papers that have together received 2.0k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer Genomics and Diagnostics (8 papers), CRISPR and Genetic Engineering (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Bladder and Urothelial Cancer Treatments (5 papers), Advanced Breast Cancer Therapies (5 papers), Protein Degradation and Inhibitors (4 papers) and Urinary and Genital Oncology Studies (4 papers). The work is most often cited by research in Cancer Research (510 citations), Molecular Biology (1.4k citations), Oncology (515 citations), Hematology (147 citations) and Immunology (247 citations). Josh Lauring has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Ben Ho Park, Mark S. Schlissel, John P. Gustin, Joseph P. Garay, Kyung Hee Yi, Abde M. Abukhdeir, Hiroyuki Konishi, Antonio C. Wolff, Peggie Cheung and Alex Kuo. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Annals of Oncology, Journal of the National Comprehensive Cancer Network and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact